QHA
- 产品代码
- QHA
- 器械名称
- X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 892.1600
- FDA 专业组
- Radiology
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 7 件
FDA 分类定义
X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology applications. X-ray angiographic imaging based coronary vascular simulation software device cannot be used alone for clinical decision making and clinical management, and is a tool intended to generate results for use and review by a qualified clinician.
该代码近三年的 510(k)(3 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K251355 | 2025-10-17 | Spectrawave, Inc. | X1-FFR | |
| K243769 | 2025-04-04 | Qfr Solutions BV | QFR (3.0) | |
| K232147 | 2024-04-09 | Pie Medical Imaging BV | CAAS Workstation |
FDA 官方分类页: QHA
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。